Alicia C. Olivo, General Counsel at NEOGENOMICS INC (NEO), sold 1,040 shares at $16.05 ($17K) on 2024-08-15, disclosed to the SEC on 2024-08-19.
Scheduled sale ($17k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NEO | SELL | 2024-11-19 | $79K | — | Filing → |
| NEO | SELL | 2024-05-17 | $17K | — | Filing → |
| NEO | SELL | 2024-02-20 | $39K | — | Filing → |